GLP-1 Receptor Agonists and Cardiovascular Disease in Patients with Type 2 Diabetes

Table 1

GLP-1 RAs.

GLP 1 RAs	Brand name	Administration	Action
Exenatide	Byetta®	Twice daily	Short acting
Exenatide-LAR	Bydureon®	Once weekly	Long acting
Lixisenatide	Lyxumia®	Once daily	Short acting
Liraglutide	Victoza®	Once daily	Long acting
Albiglutide	Eperzan®	Once weekly	Long acting
Dulaglutide	Trulicity®	Once weekly	Long acting